{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T20:37:17Z","timestamp":1754599037112},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s00105-017-4005-5","type":"journal-article","created":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T06:03:29Z","timestamp":1496297009000},"page":"526-535","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Sarkoidose"],"prefix":"10.1007","volume":"68","author":[{"given":"T.","family":"Giner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Benoit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Kneitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Goebeler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,6,1]]},"reference":[{"key":"4005_CR1","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1111\/jdv.13246","volume":"29","author":"KT Amber","year":"2015","unstructured":"Amber KT, Bloom R, Mrowietz U et al (2015) TNF-alpha: a\u00a0treatment target or cause of sarcoidosis? J\u00a0Eur Acad Dermatol Venereol 29:2104\u20132111","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4005_CR2","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1183\/13993003.00477-2016","volume":"48","author":"EV Arkema","year":"2016","unstructured":"Arkema EV, Grunewald J, Kullberg S et al (2016) Sarcoidosis incidence and prevalence: a\u00a0nationwide register-based assessment in Sweden. Eur Respir J 48:1690\u20131699","journal-title":"Eur. Respir. J."},{"key":"4005_CR3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1001\/archderm.137.1.69","volume":"137","author":"H Bachelez","year":"2001","unstructured":"Bachelez H, Senet P, Cadranel J et\u00a0al (2001) The use of tetracyclines for the treatment of sarcoidosis. Arch Dermatol 137:69\u201373","journal-title":"Arch Dermatol"},{"key":"4005_CR4","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jaad.2006.06.019","volume":"56","author":"C Badgwell","year":"2007","unstructured":"Badgwell C, Rosen T (2007) Cutaneous sarcoidosis therapy updated. J\u00a0Am Acad Dermatol 56:69\u201383","journal-title":"J. Am. Acad. Dermatol."},{"key":"4005_CR5","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1001\/archdermatol.2011.301","volume":"148","author":"RP Baughman","year":"2012","unstructured":"Baughman RP, Judson MA, Ingledue R et\u00a0al (2012) Efficacy and safety of apremilast in chronic cutaneous sarcoidosis. Arch Dermatol 148:262\u2013264","journal-title":"Arch Dermatol"},{"key":"4005_CR6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s12016-015-8492-9","volume":"49","author":"RP Baughman","year":"2015","unstructured":"Baughman RP, Lower EE (2015) Treatment of Sarcoidosis. Clin Rev Allergy Immunol 49:79\u201392","journal-title":"Clin Rev Allergy Immunol"},{"key":"4005_CR7","first-page":"333","volume":"10","author":"E Besnier","year":"1889","unstructured":"Besnier E (1889) Lupus pernio de la face; synovites fongueuses (scrofulotuberculeuses) sym\u00e9triques des extr\u00e9mites sup\u00e9rieures. Ann Dermatol Syphiligr (Paris) 10:333\u2013336","journal-title":"Ann Dermatol Syphiligr (Paris)"},{"key":"4005_CR8","first-page":"543","volume":"17","author":"C Boeck","year":"1899","unstructured":"Boeck C (1899) Multiple benign sarcoid of the skin. J\u00a0Cutan Genitourin Dis 17:543\u2013550","journal-title":"J Cutan Genitourin Dis"},{"key":"4005_CR9","first-page":"46","volume":"20","author":"KE Byg","year":"2003","unstructured":"Byg KE, Milman N, Hansen S (2003) Sarcoidosis in Denmark 1980\u20131994. A registry-based incidence study comprising 5536 patients. Sarcoidosis Vasc Diffuse Lung Dis 20:46\u201352","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"4005_CR10","doi-asserted-by":"crossref","first-page":"79","DOI":"10.5114\/reum.2016.60217","volume":"54","author":"M Chowaniec","year":"2016","unstructured":"Chowaniec M, Starba A, Wiland P (2016) Erythema nodosum \u2013 review of the literature. Reumatologia 54:79\u201382","journal-title":"Reumatologia"},{"key":"4005_CR11","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1183\/13993003.01819-2016","volume":"48","author":"YC Cozier","year":"2016","unstructured":"Cozier YC (2016) Assessing the worldwide epidemiology of sarcoidosis: challenges and future directions. Eur Respir J 48:1545\u20131548","journal-title":"Eur. Respir. J."},{"key":"4005_CR12","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.2165\/00003495-200868100-00003","volume":"68","author":"CB Doherty","year":"2008","unstructured":"Doherty CB, Rosen T (2008) Evidence-based therapy for cutaneous sarcoidosis. Drugs 68:1361\u20131383","journal-title":"Drugs"},{"key":"4005_CR13","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1001\/jamadermatol.2013.4646","volume":"149","author":"WP Drake","year":"2013","unstructured":"Drake WP, Oswald-Richter K, Richmond BW et al (2013) Oral antimycobacterial therapy in chronic cutaneous sarcoidosis: a\u00a0randomized, single-masked, placebo-controlled study. JAMA Dermatol 149:1040\u20131049","journal-title":"JAMA Dermatol"},{"key":"4005_CR14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12890-016-0332-z","volume":"16","author":"T Esteves","year":"2016","unstructured":"Esteves T, Aparicio G, Garcia-Patos V (2016) Is there any association between Sarcoidosis and infectious agents?: a\u00a0systematic review and meta-analysis. BMC Pulm Med 16:165","journal-title":"BMC Pulm Med"},{"key":"4005_CR15","doi-asserted-by":"crossref","first-page":"699.e1","DOI":"10.1016\/j.jaad.2011.11.965","volume":"66","author":"A Haimovic","year":"2012","unstructured":"Haimovic A, Sanchez M, Judson MA et\u00a0al (2012) Sarcoidosis: a\u00a0comprehensive review and update for the dermatologist: part\u00a0I. Cutaneous disease. J\u00a0Am Acad Dermatol 66:699.e1\u2013699.e18 (quiz 717\u2013698)","journal-title":"J. Am. Acad. Dermatol."},{"key":"4005_CR16","doi-asserted-by":"crossref","first-page":"719.e1","DOI":"10.1016\/j.jaad.2011.11.965","volume":"66","author":"A Haimovic","year":"2012","unstructured":"Haimovic A, Sanchez M, Judson MA et\u00a0al (2012) Sarcoidosis: a\u00a0comprehensive review and update for the dermatologist: part\u00a0II. Extracutaneous disease. J\u00a0Am Acad Dermatol 66:719.e1\u2013719.e10 (quiz 729\u2013730)","journal-title":"J. Am. Acad. Dermatol."},{"key":"4005_CR17","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s00292-015-0119-7","volume":"37","author":"K Holl-Ulrich","year":"2016","unstructured":"Holl-Ulrich K, Rose C (2016) Non-infectious granulomatous inflammation: Focus on the lungs and skin. Pathologe 37:172\u2013182","journal-title":"Pathologe"},{"key":"4005_CR18","unstructured":"Hutchinson J (1877) Case of livid papillary psoriasis. In: Hutchinson J (Hrsg) Illustrations of clinical surgery. Churchill, London, S\u00a042"},{"key":"4005_CR19","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/sj.gene.6364235","volume":"6","author":"MC Iannuzzi","year":"2005","unstructured":"Iannuzzi MC, Iyengar SK, Gray-Mcguire C et al (2005) Genome-wide search for sarcoidosis susceptibility genes in African Americans. Genes Immun 6:509\u2013518","journal-title":"Genes Immun."},{"key":"4005_CR20","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1056\/NEJMra071714","volume":"357","author":"MC Iannuzzi","year":"2007","unstructured":"Iannuzzi MC, Rybicki BA, Teirstein AS (2007) Sarcoidosis. N Engl J Med 357:2153\u20132165","journal-title":"N. Engl. J. Med."},{"key":"4005_CR21","doi-asserted-by":"publisher","unstructured":"Jamilloux Y, Cohen-Aubart F, Chapelon-Abric C et al (2017) Efficacy and safety of tumor necrosis factor antagonists in refractory sarcoidosis: A multicenter study of 132 patients. Semin Arthritis Rheum. doi:\n                        10.1016\/j.semarthrit.2017.03.005","DOI":"10.1016\/j.semarthrit.2017.03.005"},{"key":"4005_CR22","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0190-9622(90)70246-E","volume":"23","author":"E Jones","year":"1990","unstructured":"Jones E, Callen JP (1990) Hydroxychloroquine is effective therapy for control of cutaneous sarcoidal granulomas. J\u00a0Am Acad Dermatol 23:487\u2013489","journal-title":"J. Am. Acad. Dermatol."},{"key":"4005_CR23","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1183\/09031936.00000914","volume":"44","author":"MA Judson","year":"2014","unstructured":"Judson MA, Baughman RP, Costabel U et\u00a0al (2014) Safety and efficacy of ustekinumab or golimumab in patients with chronic sarcoidosis. Eur Respir J 44:1296\u20131307","journal-title":"Eur. Respir. J."},{"key":"4005_CR24","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1046\/j.1365-2133.2003.05042.x","volume":"148","author":"DJ Kouba","year":"2003","unstructured":"Kouba DJ, Mimouni D, Rencic A et al (2003) Mycophenolate mofetil may serve as a\u00a0steroid-sparing agent for sarcoidosis. Br J Dermatol 148:147\u2013148","journal-title":"Br. J. Dermatol."},{"key":"4005_CR25","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1111\/jdv.12606","volume":"29","author":"M Placa La","year":"2015","unstructured":"La Placa M, Balestri R, Mega C et\u00a0al (2015) Disfiguring papular sarcoidosis of the face: dramatic improvement with pimecrolimus. J\u00a0Eur Acad Dermatol Venereol 29:2497\u20132499","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4005_CR26","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/09546630410023584","volume":"15","author":"A Mosam","year":"2004","unstructured":"Mosam A, Morar N (2004) Recalcitrant cutaneous sarcoidosis: an evidence-based sequential approach. J\u00a0Dermatolog Treat 15:353\u2013359","journal-title":"J Dermatolog Treat"},{"key":"4005_CR27","first-page":"829","volume":"8","author":"FR Ochsendorf","year":"2010","unstructured":"Ochsendorf FR (2010) Use of antimalarials in dermatology. J\u00a0Dtsch Dermatol Ges 8:829\u2013844","journal-title":"J Dtsch Dermatol Ges"},{"key":"4005_CR28","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.jaad.2012.10.056","volume":"68","author":"RJ Pariser","year":"2013","unstructured":"Pariser RJ, Paul J, Hirano S et al (2013) A double-blind, randomized, placebo-controlled trial of adalimumab in the treatment of cutaneous sarcoidosis. J Am Acad Dermatol 68:765\u2013773","journal-title":"J. Am. Acad. Dermatol."},{"key":"4005_CR29","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/MOH.0000000000000301","volume":"24","author":"P Sakthivel","year":"2017","unstructured":"Sakthivel P, Bruder D (2017) Mechanism of granuloma formation in sarcoidosis. Curr Opin Hematol 24:59\u201365","journal-title":"Curr. Opin. Hematol."},{"key":"4005_CR30","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.det.2015.03.006","volume":"33","author":"M Sanchez","year":"2015","unstructured":"Sanchez M, Haimovic A, Prystowsky S (2015) Sarcoidosis. Dermatol Clin 33:389\u2013416","journal-title":"Dermatol Clin"},{"key":"4005_CR31","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1165\/rcmb.4782","volume":"27","author":"H Sato","year":"2002","unstructured":"Sato H, Grutters JC, Pantelidis P et al (2002) HLA-DQB1*0201: a\u00a0marker for good prognosis in British and Dutch patients with sarcoidosis. Am J Respir Cell Mol Biol 27:406\u2013412","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"4005_CR32","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1164\/ajrccm.164.5.2007056","volume":"164","author":"M Schurmann","year":"2001","unstructured":"Schurmann M, Reichel P, Muller-Myhsok B et al (2001) Results from a\u00a0genome-wide search for predisposing genes in sarcoidosis. Am J Respir Crit Care Med 164:840\u2013846","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"4005_CR33","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1136\/thx.2007.094060","volume":"63","author":"A Sverrild","year":"2008","unstructured":"Sverrild A, Backer V, Kyvik KO et al (2008) Heredity in sarcoidosis: a\u00a0registry-based twin study. Thorax 63:894\u2013896","journal-title":"Thorax"},{"key":"4005_CR34","doi-asserted-by":"publisher","unstructured":"Thi Hong Nguyen C, Kambe N, Kishimoto I et al (2017) Serum soluble interleukin-2 receptor level is more sensitive than angiotensin-converting enzyme or lysozyme for diagnosis of sarcoidosis and may be a\u00a0marker of multiple organ involvement. J Dermatol. doi:\n                        10.1111\/1346-8138.13792","DOI":"10.1111\/1346-8138.13792"},{"key":"4005_CR35","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1111\/jdv.13760","volume":"30","author":"P Ungprasert","year":"2016","unstructured":"Ungprasert P, Wetter DA, Crowson CS et al (2016) Epidemiology of cutaneous sarcoidosis, 1976\u20132013: a\u00a0population-based study from Olmsted County, Minnesota. J\u00a0Eur Acad Dermatol Venereol 30:1799\u20131804","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4005_CR36","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(13)60680-7","volume":"383","author":"D Valeyre","year":"2014","unstructured":"Valeyre D, Prasse A, Nunes H et\u00a0al (2014) Sarcoidosis. Lancet 383:1155\u20131167","journal-title":"Lancet"},{"key":"4005_CR37","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0738-081X(86)90036-2","volume":"4","author":"NK Veien","year":"1986","unstructured":"Veien NK (1986) Cutaneous sarcoidosis: prognosis and treatment. Clin Dermatol 4:75\u201387","journal-title":"Clin. Dermatol."},{"issue":"suppl 12","key":"4005_CR38","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2133.1976.tb02269.x","volume":"94","author":"J Verbov","year":"1976","unstructured":"Verbov J (1976) The place of intralesional steroid therapy in dermatology. Br J Dermatol 94(suppl 12):51\u201358","journal-title":"Br. J. Dermatol."},{"key":"4005_CR39","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1164\/ajrccm.163.1.9906071","volume":"163","author":"J Wahlstrom","year":"2001","unstructured":"Wahlstrom J, Katchar K, Wigzell H et\u00a0al (2001) Analysis of intracellular cytokines in CD4+ and CD8+ lung and blood T cells in sarcoidosis. Am J Respir Crit Care Med 163:115\u2013121","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"4005_CR40","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00105-015-3646-5","volume":"66","author":"B Weidenthaler-Barth","year":"2015","unstructured":"Weidenthaler-Barth B, Steinbrink K, Kummel A et al (2015) Sarcoidosis : Organ involvement, diagnosis, current treatment. Hautarzt 66:549\u2013563","journal-title":"Hautarzt"},{"key":"4005_CR41","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1183\/09031936.03.00010403","volume":"21","author":"MW Ziegenhagen","year":"2003","unstructured":"Ziegenhagen MW, Rothe ME, Schlaak M et\u00a0al (2003) Bronchoalveolar and serological parameters reflecting the severity of sarcoidosis. Eur Respir J 21:407\u2013413","journal-title":"Eur. Respir. J."}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-017-4005-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-017-4005-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-017-4005-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,7,3]],"date-time":"2017-07-03T08:10:32Z","timestamp":1499069432000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-017-4005-5"}},"subtitle":["Dermatologischer Blick auf eine seltene Multisystemerkrankung"],"short-title":[],"issued":{"date-parts":[[2017,6,1]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["4005"],"URL":"https:\/\/doi.org\/10.1007\/s00105-017-4005-5","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,1]]}}}